Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Department of Statistics, Dongguk University, Seoul, Republic of Korea.
Metabolism. 2023 Apr;141:155514. doi: 10.1016/j.metabol.2023.155514. Epub 2023 Feb 4.
Little is known about the subtypes of type 2 diabetes (T2D) and their association with clinical outcomes in Asians.
We performed data-driven cluster analysis in patients with newly diagnosed drug-naive T2D (n = 756) from the Korean Genome and Epidemiology Study. Clusters were based on five variables (age at diagnosis, BMI, HbA1c, and HOMA2 β-cell function, and insulin resistance).
We identified four clusters of patients with T2D according to k-means clustering: cluster 1 (22.4 %, severe insulin-resistant diabetes [SIRD]), cluster 2 (32.7 %, mild age-related diabetes [MARD]), cluster 3 (32.7 %, mild obesity-related diabetes [MOD]), and cluster 4 (12.3 %, severe insulin-deficient diabetes [SIDD]). During 14 years of follow-up, individuals in the SIDD cluster had the highest risk of initiation of glucose-lowering therapy compared to individuals in the other three clusters. Individuals in the MARD and SIDD clusters showed the highest risk of chronic kidney disease and cardiovascular disease, and individuals in the MOD clusters showed the lowest risk after adjusting for other risk factors (P < 0.05).
Patients with T2D can be categorized into four subgroups with different glycemic deterioration and risks of diabetes complications. Individualized management might be helpful for better clinical outcomes in Asian patients with different T2D subgroups.
对于 2 型糖尿病(T2D)的亚型及其与亚洲人群临床结局的关系知之甚少。
我们对来自韩国基因组与流行病学研究的 756 例初诊未用药的 T2D 患者进行了基于数据的聚类分析。聚类是基于五个变量(诊断时的年龄、BMI、HbA1c、HOMA2 β细胞功能和胰岛素抵抗)进行的。
根据 k-均值聚类,我们确定了 T2D 患者的四个聚类:聚类 1(22.4%,严重胰岛素抵抗性糖尿病[SIRD])、聚类 2(32.7%,轻度与年龄相关的糖尿病[MARD])、聚类 3(32.7%,轻度肥胖相关的糖尿病[MOD])和聚类 4(12.3%,严重胰岛素缺乏性糖尿病[SIDD])。在 14 年的随访期间,与其他三个聚类相比,SIDD 聚类的患者开始降糖治疗的风险最高。MARD 和 SIDD 聚类的患者发生慢性肾脏病和心血管疾病的风险最高,MOD 聚类的患者发生这些疾病的风险最低,在调整其他危险因素后(P<0.05)。
T2D 患者可分为四个亚组,其血糖恶化和糖尿病并发症风险不同。对于不同 T2D 亚组的亚洲患者,个体化管理可能有助于获得更好的临床结局。